Jose-Alberto Palma1, Horacio Kaufmann1. 1. Dysautonomia Center, Department of Neurology, New York University School of Medicine, New York.
Abstract
BACKGROUND: Orthostatic hypotension (OH) is a sustained fall in blood pressure on standing which can cause symptoms of organ hypoperfusion. OH is associated with increased morbidity and mortality and leads to a significant number of hospital admissions particularly in the elderly (233 per 100,000 patients over 75 years of age in the US). OH can be due to volume depletion, blood loss, large varicose veins, medications, or due to defective activation of sympathetic nerves and reduced norepinephrine release upon standing (i.e., neurogenic OH). METHODS AND FINDINGS: Literature review. Neurogenic OH is a frequent and disabling problem in patients with synucleinopathies such as Parkinson disease, multiple system atrophy, and pure autonomic failure, and is commonly associated with supine hypertension. Several pharmacological and non-pharmacological therapeutic options are available. CONCLUSIONS: Here we review the epidemiology, diagnosis, and management of neurogenic OH, and provide an algorithm for its treatment emphasizing the importance of removing aggravating factors, implementing non-pharmacologic measures, and selecting appropriate pharmacological treatments.
BACKGROUND:Orthostatic hypotension (OH) is a sustained fall in blood pressure on standing which can cause symptoms of organ hypoperfusion. OH is associated with increased morbidity and mortality and leads to a significant number of hospital admissions particularly in the elderly (233 per 100,000 patients over 75 years of age in the US). OH can be due to volume depletion, blood loss, large varicose veins, medications, or due to defective activation of sympathetic nerves and reduced norepinephrine release upon standing (i.e., neurogenic OH). METHODS AND FINDINGS: Literature review. Neurogenic OH is a frequent and disabling problem in patients with synucleinopathies such as Parkinson disease, multiple system atrophy, and pure autonomic failure, and is commonly associated with supine hypertension. Several pharmacological and non-pharmacological therapeutic options are available. CONCLUSIONS: Here we review the epidemiology, diagnosis, and management of neurogenic OH, and provide an algorithm for its treatment emphasizing the importance of removing aggravating factors, implementing non-pharmacologic measures, and selecting appropriate pharmacological treatments.
Authors: S Toru; T Yokota; A Inaba; M Yamawaki; M Yamada; H Mizusawa; M Hayashi Journal: J Neurol Neurosurg Psychiatry Date: 1999-06 Impact factor: 10.154
Authors: Luis E Okamoto; André Diedrich; Franz J Baudenbacher; René Harder; Jonathan S Whitfield; Fahad Iqbal; Alfredo Gamboa; Cyndya A Shibao; Bonnie K Black; Satish R Raj; David Robertson; Italo Biaggioni Journal: Hypertension Date: 2016-06-06 Impact factor: 10.190
Authors: Horacio Kaufmann; Daniela Saadia; Andrei Voustianiouk; David S Goldstein; Courtney Holmes; Melvin D Yahr; Rachel Nardin; Roy Freeman Journal: Circulation Date: 2003-07-28 Impact factor: 29.690
Authors: Lucy Norcliffe-Kaufmann; Horacio Kaufmann; Jose-Alberto Palma; Cyndya A Shibao; Italo Biaggioni; Amanda C Peltier; Wolfgang Singer; Phillip A Low; David S Goldstein; Christopher H Gibbons; Roy Freeman; David Robertson Journal: Ann Neurol Date: 2018-03-10 Impact factor: 10.422
Authors: Jonathan A Hyam; Holly A Roy; Yongzhi Huang; Sean Martin; Shouyan Wang; Jodi Rippey; Terry J Coyne; Ian Stewart; Graham Kerr; Peter Silburn; David J Paterson; Tipu Z Aziz; Alexander L Green Journal: Clin Auton Res Date: 2019-09-06 Impact factor: 4.435
Authors: Arthur Lo; Lucy Norcliffe-Kaufmann; Ross Vickery; David Bourdet; Jitendra Kanodia Journal: Clin Auton Res Date: 2021-03-29 Impact factor: 4.435